Home / Inspections / 1287588

FDA Inspection 1287588 — Baxalta US Incorporated

Baxalta US Incorporated — FEI 2011021

The FDA completed an inspection of Baxalta US Incorporated on November 7, 2025 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 7, 2025
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Facility

Other inspections at this facility

  • 1208375 (VAI Wed May 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1072937 (VAI Fri Nov 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 998105 (VAI Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 923173 (VAI Fri Mar 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 801949 (VAI Thu Sep 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources